NCM·Healthcare·$114M·#362 / 520 in Healthcare
RPID Rapid Micro Biosystems, Inc.
32HIGH RISK
CATEGORY BREAKDOWN
GROWTH32
QUALITY2
STABILITY18
VALUATION86
GOVERNANCE76
METRIC BREAKDOWN
Revenue Growth (YoY)
Year-over-year revenue growth rate
+19.7%
32
> 50% strong
Gross Margin
Revenue retained after direct costs
3.1%
4
> 50% strong
Cash Runway
Months of cash at current burn rate
5 months
9
> 24 months ideal
Debt / Equity
Total debt relative to shareholder equity
71.9%
35
< 25% strong
Price / Sales
Market cap relative to trailing revenue
3.4x
86
< 3x strong
Rule of 40
Growth rate plus operating margin
-121
0
> 40 excellent
Insider Ownership
Percentage of shares held by insiders
9.9%
65
> 20% strong
Share Dilution (12M)
Share count increase over last 12 months
-5.5%
100
< 5% ideal
SCORE HISTORY
RELATED STOCKS
COMPARE RPID WITH…
OR QUICK-COMPARE SECTOR PEERS
SCORE ALERT
Get notified when RPID's score changes by 5+ points.
DATA INFO
Last updated: May 4, 2026
Sources: SEC EDGAR, Financial Modeling Prep, Yahoo Finance. Not financial advice.